Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 54, n. Especial, p. e01005, 2018. DOI: 10.1590/s2175-97902018000001005. Disponível em: https://revistas.usp.br/bjps/article/view/153903.. Acesso em: 4 may. 2024.